Abstract
Background Low-density lipoprotein cholesterol (LDL-C) is an important biomarker for determining cardiovascular risk and regulating lipid lowering therapy. Therefore, the accurate estimation of LDL-C concentration is essential in cardiovascular disease diagnosis and prognosis. Sampson recently proposed a new formula for the estimation of LDL-C. However, little is known regarding the validation of this formula.
Objectives This study aimed to validate this new formula with other well-known formulas in Turkish population, composed of adults.
Methods A total of 88,943 participants above 18 years old at Sivas Cumhuriyet University Hospital (Sivas, Turkey) were included to this study. LDL-C was directly measured by homogeneous assays, i.e., Roche, Beckman and Siemens and estimated by Friedewald’s, Martin/Hopkins’, extended Martin/Hopkins’ and Sampson’s formulas. The accuracies between the estimations obtained by the formulas and the direct measurements were evaluated both in general and separately for the LDL-C, TG and non-HDL-C sublevels. Linear regression analysis was applied and residual error plots were generated between each estimation and direct measurement method. Coefficient of determination (R2) and mean absolute deviations were also calculated.
Results The results showed that the extended Martin/Hopkins approach was the overall most accurate approach for LDL-C estimation. The results also showed that the highest concordances were obtained between the direct assays with the extended Martin/Hopkins formula calculated with the median statistics obtained from our own population. On the other hand, it was observed that the results of the methods may differ in different assays. Although the best performance was obtained by the Sampson formula in patients with “low LDL-C level and hypertriglyceridemia”, the extended Martin/Hopkins approach, calculated from the median statistics of our population, gave the most accurate results in patients with “low LDL-C level or hypertriglyceridemia”.
Conclusions In conclusion, in patients with a low LDL-C level or hypertriglyceridemia, the extended Martin/Hopkins method; in patients with a low LDL-C level and hypertriglyceridemia, the Sampson method may be preferred. The validity of the Martin Hopkins’ and Sampson’s formulas has to be further investigated in different populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the Research Fund of Erciyes University [TSG-2021-10912]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Sivas Cumhuriyet University Noninvasive Clinical Research Ethics Committee (2020-03/05).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
Data cannot be shared publicly because of patient confidentiality. Data are available from the Sivas Cumhuriyet University Institutional Data Access / Ethics Committee (contact via gokaek2014@gmail.com or +903464870000/2092) for researchers who meet the criteria for access to confidential data.
